Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of DCM Shriram Fine Chemicals
Quarter-by-quarter operating performance
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 93.35 | 113.09 | 96.90 | 96.95 | 93.08 |
| Expenses + | 88.47 | 105.46 | 98.39 | 96.63 | 95.59 |
| Operating Profit | 4.88 | 7.63 | -1.49 | 0.32 | -2.51 |
| OPM % | 5.23% | 6.75% | -1.54% | 0.33% | -2.70% |
| Other Income + | 0.99 | 1.01 | 0.68 | 0.81 | 0.74 |
| Interest | 0.41 | 0.50 | 0.22 | 0.24 | 0.69 |
| Depreciation | 2.20 | 2.16 | 2.17 | 2.11 | 2.06 |
| Profit before tax | 3.26 | 5.98 | -3.20 | -1.22 | -4.52 |
| Tax % | 26.69% | 26.09% | -20.94% | 22.13% | -15.27% |
| Net Profit + | 2.39 | 4.42 | -2.53 | -1.49 | -3.83 |
| EPS in Rs | 0.24 | 0.44 | -0.25 | -0.17 | -0.44 |
Financials of DCM Shriram Fine Chemicals
Annual income statement trend
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales + | 429 | 386 |
| Expenses + | 396 | 382 |
| Operating Profit | 33 | 4 |
| OPM % | 8% | 1% |
| Other Income + | 4 | 3 |
| Interest | 2 | 1 |
| Depreciation | 9 | 8 |
| Profit before tax | 26 | -3 |
| Tax % | 26% | 12% |
| Net Profit + | 19 | -4 |
| EPS in Rs | 1.92 | -0.40 |
| Dividend Payout % | 0% | -99% |
Financials of DCM Shriram Fine Chemicals
Capital structure and asset base
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 17 | 17 |
| Reserves | 198 | 194 |
| Borrowings + | 13 | 13 |
| Other Liabilities + | 80 | 72 |
| Total Liabilities | 308 | 295 |
| Fixed Assets + | 130 | 103 |
| CWIP | 0 | 0 |
| Investments | 23 | 33 |
| Other Assets + | 155 | 159 |
| Total Assets | 308 | 295 |
Financials of DCM Shriram Fine Chemicals
Operating, investing and financing cash movement
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity + | 14 | 16 |
| Cash from Investing Activity + | 0 | 11 |
| Cash from Financing Activity + | -15 | -6 |
| Net Cash Flow | 0 | 21 |
| Free Cash Flow | 12 | 35 |
| CFO/OP | 72% | 565% |
Financials of DCM Shriram Fine Chemicals
Working capital efficiency and return ratios
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 70 | 67 |
| Inventory Days | 74 | 64 |
| Days Payable | 80 | 78 |
| Cash Conversion Cycle | 65 | 53 |
| Working Capital Days | 72 | 78 |
| ROCE % | -1% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…